These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
526 related articles for article (PubMed ID: 28843831)
1. ImmunoPET imaging of tissue factor expression in pancreatic cancer with Hernandez R; England CG; Yang Y; Valdovinos HF; Liu B; Wong HC; Barnhart TE; Cai W J Control Release; 2017 Oct; 264():160-168. PubMed ID: 28843831 [TBL] [Abstract][Full Text] [Related]
2. ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors. Hernandez R; Sun H; England CG; Valdovinos HF; Barnhart TE; Yang Y; Cai W Mol Pharm; 2016 Jul; 13(7):2563-70. PubMed ID: 27280694 [TBL] [Abstract][Full Text] [Related]
3. ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer. England CG; Kamkaew A; Im HJ; Valdovinos HF; Sun H; Hernandez R; Cho SY; Dunphy EJ; Lee DS; Barnhart TE; Cai W Mol Pharm; 2016 Jun; 13(6):1958-66. PubMed ID: 27054683 [TBL] [Abstract][Full Text] [Related]
4. Immuno-PET of tissue factor in pancreatic cancer. Hong H; Zhang Y; Nayak TR; Engle JW; Wong HC; Liu B; Barnhart TE; Cai W J Nucl Med; 2012 Nov; 53(11):1748-54. PubMed ID: 22988057 [TBL] [Abstract][Full Text] [Related]
5. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody. Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560 [TBL] [Abstract][Full Text] [Related]
6. ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment. Luo H; England CG; Goel S; Graves SA; Ai F; Liu B; Theuer CP; Wong HC; Nickles RJ; Cai W Mol Pharm; 2017 May; 14(5):1646-1655. PubMed ID: 28292180 [TBL] [Abstract][Full Text] [Related]
7. Immuno-PET imaging of tumor endothelial marker 8 (TEM8). Kuo F; Histed S; Xu B; Bhadrasetty V; Szajek LP; Williams MR; Wong K; Wu H; Lane K; Coble V; Vasalatiy O; Griffiths GL; Paik CH; Elbuluk O; Szot C; Chaudhary A; St Croix B; Choyke P; Jagoda EM Mol Pharm; 2014 Nov; 11(11):3996-4006. PubMed ID: 24984190 [TBL] [Abstract][Full Text] [Related]
8. Development of a novel long-lived immunoPET tracer for monitoring lymphoma therapy in a humanized transgenic mouse model. Natarajan A; Habte F; Gambhir SS Bioconjug Chem; 2012 Jun; 23(6):1221-9. PubMed ID: 22621257 [TBL] [Abstract][Full Text] [Related]
9. ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment. Shi S; Hong H; Orbay H; Graves SA; Yang Y; Ohman JD; Liu B; Nickles RJ; Wong HC; Cai W Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1295-303. PubMed ID: 25801992 [TBL] [Abstract][Full Text] [Related]
10. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII. Nielsen CH; Jeppesen TE; Kristensen LK; Jensen MM; El Ali HH; Madsen J; Wiinberg B; Petersen LC; Kjaer A J Nucl Med; 2016 Jul; 57(7):1112-9. PubMed ID: 27013699 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793 [TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105. Hong H; Severin GW; Yang Y; Engle JW; Zhang Y; Barnhart TE; Liu G; Leigh BR; Nickles RJ; Cai W Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):138-48. PubMed ID: 21909753 [TBL] [Abstract][Full Text] [Related]
13. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging. Perk LR; Vosjan MJ; Visser GW; Budde M; Jurek P; Kiefer GE; van Dongen GA Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):250-9. PubMed ID: 19763566 [TBL] [Abstract][Full Text] [Related]
14. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII. Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146 [TBL] [Abstract][Full Text] [Related]
15. ImmunoPET imaging of CD38 in murine lymphoma models using Kang L; Jiang D; England CG; Barnhart TE; Yu B; Rosenkrans ZT; Wang R; Engle JW; Xu X; Huang P; Cai W Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1372-1381. PubMed ID: 29450576 [TBL] [Abstract][Full Text] [Related]
16. CD38 as a PET Imaging Target in Lung Cancer. Ehlerding EB; England CG; Jiang D; Graves SA; Kang L; Lacognata S; Barnhart TE; Cai W Mol Pharm; 2017 Jul; 14(7):2400-2406. PubMed ID: 28573863 [TBL] [Abstract][Full Text] [Related]
17. Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30. Perk LR; Stigter-van Walsum M; Visser GW; Kloet RW; Vosjan MJ; Leemans CR; Giaccone G; Albano R; Comoglio PM; van Dongen GA Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1857-67. PubMed ID: 18491091 [TBL] [Abstract][Full Text] [Related]
18. ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer. Chen W; Li M; Younis MH; Barnhart TE; Jiang D; Sun T; Lang JM; Engle JW; Zhou M; Cai W Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):861-870. PubMed ID: 34519889 [TBL] [Abstract][Full Text] [Related]
19. In Vitro and In Vivo Characterization of Allen KJH; Jiao R; Li J; Beckford-Vera DR; Dadachova E Molecules; 2022 Oct; 27(19):. PubMed ID: 36235126 [No Abstract] [Full Text] [Related]
20. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies. Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]